248 related articles for article (PubMed ID: 35784347)
1. Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization.
Shi Y; Li J; Chen H; Hu Y; Tang L; Zhou X; Tao M; Lv Z; Chen S; Qiu A; Liu N
Front Immunol; 2022; 13():899140. PubMed ID: 35784347
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization.
Zhou X; Chen H; Shi Y; Li J; Ma X; Du L; Hu Y; Tao M; Zhong Q; Yan D; Zhuang S; Liu N
Front Immunol; 2023; 14():1137332. PubMed ID: 36911746
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of HDAC6 in clinical peritoneal dialysis patients and its pathogenic role on peritoneal angiogenesis.
Shi Y; Ni J; Tao M; Ma X; Wang Y; Zang X; Hu Y; Qiu A; Zhuang S; Liu N
Ren Fail; 2020 Nov; 42(1):890-901. PubMed ID: 32862739
[TBL] [Abstract][Full Text] [Related]
4. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.
Shi Y; Tao M; Wang Y; Zang X; Ma X; Qiu A; Zhuang S; Liu N
J Pathol; 2020 Jan; 250(1):79-94. PubMed ID: 31579944
[TBL] [Abstract][Full Text] [Related]
5. Tubastatin alleviates epidural fibrosis via negatively targeting TGFβ/PI3K/Akt pathway.
Tao L; Wu L; Ge Y
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):231-236. PubMed ID: 38678601
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 6 inhibition counteracts the epithelial-mesenchymal transition of peritoneal mesothelial cells and prevents peritoneal fibrosis.
Xu L; Liu N; Gu H; Wang H; Shi Y; Ma X; Ma S; Ni J; Tao M; Qiu A; Zhuang S
Oncotarget; 2017 Oct; 8(51):88730-88750. PubMed ID: 29179471
[TBL] [Abstract][Full Text] [Related]
7. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
8. Requirement of Histone Deacetylase 6 for Interleukin-6 Induced Epithelial-Mesenchymal Transition, Proliferation, and Migration of Peritoneal Mesothelial Cells.
Shi Y; Tao M; Ni J; Tang L; Liu F; Chen H; Ma X; Hu Y; Zhou X; Qiu A; Zhuang S; Liu N
Front Pharmacol; 2021; 12():722638. PubMed ID: 34526901
[No Abstract] [Full Text] [Related]
9. Delayed administration of suramin attenuates peritoneal fibrosis in rats.
Xiong C; Liu N; Shao X; Sharif S; Zou H; Zhuang S
BMC Nephrol; 2019 Nov; 20(1):411. PubMed ID: 31727005
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Transglutaminase 2 Reduces Peritoneal Injury in a Chlorhexidine-Induced Peritoneal Fibrosis Model.
Kunoki S; Tatsukawa H; Sakai Y; Kinashi H; Kariya T; Suzuki Y; Mizuno M; Yamaguchi M; Sasakura H; Ikeno M; Takeuchi K; Ishimoto T; Hitomi K; Ito Y
Lab Invest; 2023 Apr; 103(4):100050. PubMed ID: 36870292
[TBL] [Abstract][Full Text] [Related]
11. Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-β1/Smad3 signaling pathway in vitro.
Yang Y; Liu K; Liang Y; Chen Y; Chen Y; Gong Y
Int J Clin Exp Pathol; 2015; 8(3):2746-54. PubMed ID: 26045780
[TBL] [Abstract][Full Text] [Related]
12. Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes.
Choi SY; Ryu Y; Kee HJ; Cho SN; Kim GR; Cho JY; Kim HS; Kim IK; Jeong MH
Vascul Pharmacol; 2015 Sep; 72():130-40. PubMed ID: 25921924
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling.
Ueno T; Nakashima A; Doi S; Kawamoto T; Honda K; Yokoyama Y; Doi T; Higashi Y; Yorioka N; Kato Y; Kohno N; Masaki T
Kidney Int; 2013 Aug; 84(2):297-307. PubMed ID: 23486522
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase 6 inhibition mitigates renal fibrosis by suppressing TGF-β and EGFR signaling pathways in obstructive nephropathy.
Chen X; Yu C; Hou X; Li J; Li T; Qiu A; Liu N; Zhuang S
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1003-F1014. PubMed ID: 33103445
[TBL] [Abstract][Full Text] [Related]
15. Characterization of infiltrating macrophages in high glucose-induced peritoneal fibrosis in rats.
Hu W; Jiang Z; Zhang Y; Liu Q; Fan J; Luo N; Dong X; Yu X
Mol Med Rep; 2012 Jul; 6(1):93-9. PubMed ID: 22552745
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of AK142426 suppresses M2 macrophage polarization and inflammation in peritoneal fibrosis via binding to c-Jun.
Shao Q; Jiang C; Zhang Q; Liu J; Jin B; Zhao M; Xia Y
J Gene Med; 2023 Sep; 25(9):e3524. PubMed ID: 37194352
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C beta deficiency increases glucose-mediated peritoneal damage via M1 macrophage polarization and up-regulation of mesothelial protein kinase C alpha.
Balzer MS; Helmke A; Ackermann M; Casper J; Dong L; Hiss M; Kiyan Y; Rong S; Timrott K; von Vietinghoff S; Wang L; Haller H; Shushakova N
Nephrol Dial Transplant; 2019 Jun; 34(6):947-960. PubMed ID: 30247663
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D can ameliorate chlorhexidine gluconate-induced peritoneal fibrosis and functional deterioration through the inhibition of epithelial-to-mesenchymal transition of mesothelial cells.
Lee YC; Hung SY; Liou HH; Lin TM; Tsai CH; Lin SH; Tsai YS; Chang MY; Wang HH; Ho LC; Chen YT; Wu CF; Chen HC; Chen HP; Liu KW; Chen CI; She KM; Wang HK; Lin CW; Chiou YY
Biomed Res Int; 2015; 2015():595030. PubMed ID: 26495304
[TBL] [Abstract][Full Text] [Related]
19. HDAC6-dependent deacetylation of TAK1 enhances sIL-6R release to promote macrophage M2 polarization in colon cancer.
Xu G; Niu L; Wang Y; Yang G; Zhu X; Yao Y; Zhao G; Wang S; Li H
Cell Death Dis; 2022 Oct; 13(10):888. PubMed ID: 36270986
[TBL] [Abstract][Full Text] [Related]
20. Adipose-derived mesenchymal stem cells attenuate dialysis-induced peritoneal fibrosis by modulating macrophage polarization via interleukin-6.
Yang CY; Chang PY; Chen JY; Wu BS; Yang AH; Lee OK
Stem Cell Res Ther; 2021 Mar; 12(1):193. PubMed ID: 33741073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
